activ of serum alphaamylas in cystic fibrosi a new method which use a differenti inhibitor to measur pancreat and salivari type alphaamylas ec 3211 wa appli to serum sampl from 46 cystic fibrosi cf patient age rang 4 14 year and 50 control of the same age group the level of pancreat type amylas were lower in the cf patient median 265 iu1 than the control median 815 p less than 0001 the result for salivarytyp enzym howev did not support the previous report find of higher than usual level in cf patient thi discrep is probabl due to differ in analyt method it is felt that thi procedur will be of valu in the investig of patient for cystic fibrosi and other pancreat disord